Cite
HARVARD Citation
Yamamoto, S. et al. (2021). Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201. European journal of cancer. pp. 307-315. [Online].